Johnson & Johnson Coughs Up $33 Million Over Recalled Nonprescription Meds

Published: May 25, 2017

Johnson & Johnson will pay $33 million to Illinois and at least 40 other states to settle allegations that a subsidiary falsely claimed it was following federal manufacturing practices — a situation the states said led to the recall of common drugs including Tylenol, Motrin, Benadryl and Sudafed.

Illinois' portion of the settlement is more than $1 million, which will go to the state, according to the Illinois attorney general's office.

The states alleged that Johnson & Johnson subsidiary McNeil-PPC committed consumer fraud by selling drugs that it falsely claimed were manufactured following federal practices.

Back to news